The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium (Q38793676)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 May 2017
  • TheBRCA1c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
edit
Language Label Description Also known as
English
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
scientific article published on 10 May 2017
  • TheBRCA1c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

Statements

The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Ylva Paulsson-Karlsson
Inge Søkilde Pedersen
Valeria Viassolo
Christie J Van Asperen
Encarna Gómez García
55
1 reference
28 June 2019
1
1 reference
28 June 2019
15-20
1 reference
28 June 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit